Automated vital signs solutions for long term aged care
As the elderly population grows and resident acuity levels increase, your long-term care facilities may be experiencing an increased demand for care. With cost constraints
MiOK and ‘U alright mate?’ pair for men’s wellbeing
“U alright mate?” is proud to partner with global technology business DB Results and take up the wellbeing app MiOK to further support its community.
Lenexa pressure injury prevention trials show promise in regional Victoria
The Lenexa Medical Quality-of-Care Pressure Injury Management System is a world first medical device undergoing trials at one of the largest regional hospitals in Victoria,
ResApp screening coughs for COVID-19 returns promising trial results
Early results of the ResApp trial of more than 700 people have been released but are still to be peer-reviewed. The trial, which was funded
World’s first lung scanner to change millions of lives
Australians with lung conditions will be able to access the world’s first and only dedicated lung scanner, which was developed and built in Australia, at
Civica welcomes proposed design for new Support at Home Program
Civica Care, an Australian leader in innovative software for community care organisations, is helping the Aged Care industry across Australia through their Carelink Suite software.
New lifesaving CGM device for Australians with diabetes
Australians with diabetes will now have access to the next-generation Dexcom G6 Continuous Glucose Monitoring (CGM), ensuring they can use the latest technology to manage
FiveP Australia launches Baret, a digi-communications tool for frontliners
FiveP Australia, a Melbourne-based Microsoft Gold partner, has launched Baret to help solve one of the most common communication challenges for frontline workers across the
Healthcare network announces new board and post-COVID opportunities
Plexus Research has created one of the largest clinical trial network for healthcare products in South Australia targeting drugs, devices, and digital solutions (3D) for
Latest Technique for Cancer Treatment
Its inventor, UQ Diamantina Institute’s Dr. Fiona Simpson, said it could be used to show how long antibodies stayed active in patients, or when antibodies
